NEWS

Dolor sit amet

February 3, 2018

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam.

In Other News

Meso Foundation awards $300,000 in grants to mesothelioma research projects

The Mesothelioma Applied Research Foundation announced its latest research grant recipients, awarding a total of $300,000 at the International Symposium on Malignant Mesothelioma in Philadelphia

MesoTV: Caring for the Caregiver: Putting On Your Oxygen Mask First

Many of our MesoTV episodes and other educational materials discuss the patient: their stories, their emotions, the science behind their diagnosis. This episode is solely

Vivace Therapeutics Receives FDA Orphan Drug Designation for VT3989 for Mesothelioma Treatment

Vivace Therapeutics, a company that develops cancer treatments, announced on July 30, 2025, that the U.S. Food and Drug Administration (FDA) has granted its experimental

1717 K Street NW, Suite 900

(877) 363-6376

SUPPORT

Patient and caregiver support and resources

Understanding Mesothelioma

Financial assistance for patients

Support groups

Peer-to-peer support

We can help guide you through the selection of medical specialists and treatments including clinical trials.

Explore topics about mesothelioma

WATCH, LISTEN, READ, LEARN

International Symposium on Malignant Mesothelioma

MesoTV

Meet the Mesothelioma Experts (MTME)

Read about recent research and treatment advances

We can help guide you through the selection of medical specialists and treatments including clinical trials.

PARTICIPATE

International Symposium on Malignant Mesothelioma

Mesothelioma Awareness Day

Fundraise for mesothelioma

Advocacy

Donate

Explore topics about mesothelioma

Dolor sit amet

In Other News

Meso Foundation awards $300,000 in grants to mesothelioma research projects

MesoTV: Caring for the Caregiver: Putting On Your Oxygen Mask First

Vivace Therapeutics Receives FDA Orphan Drug Designation for VT3989 for Mesothelioma Treatment

Share:

Subscribe to our news

Patients and Families

About

Researchers

Read